Skip to main content

Differential Diagnosis of HIV-Associated Neurocognitive Disorders

  • Living reference work entry
  • First Online:
Encyclopedia of AIDS

Definition

Cognitive dysfunction in human immunodeficiency virus (HIV)-infected patients is common and can be a difficult diagnosis for the treating physician in the face of multiple potential causes. Cognitive dysfunction persists in up to 50 % of HIV-infected patients in the post-highly active antiretroviral therapy (post-HAART) era, with milder forms predominating (Cysique et al. 2004; Cohen and Gongvatana 2010). The differential diagnoses are divided into those relevant to virally suppressed patients and those that are not, with HIV-associated neurocognitive disorder (HAND) common to both groups.

In patients who are virally suppressed, the diagnoses more commonly encountered, apart from HAND, are substance abuse, psychiatric illness, and hepatitis C, both through its direct effects on cognition and through hepatic encephalopathy. The clinical significance of ageing and neurodegenerative diseases such as Alzheimer’s and vascular cognitive impairment is not presently clear though the...

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Institutional subscriptions

References

  • Ances BM, Vaida F, Yeh MJ, Liang CL, Buxton RB, Letendre S, McCutchen JA, Ellis RJ. HIV infection and aging independently affect brain function as measured by functional magnetic resonance imaging. J Infect Dis. 2010;201:336–40.

    Article  PubMed Central  PubMed  Google Scholar 

  • Ances BM, Benzinger TL, Christensen JJ, Thomas J, Venkat R, Teshome M, Aldea P, Fagan AM, Holtzman D, Morris JC, Clifford DB. 11C-PiB Imaging of human immunodeficiency virus–associated neurocognitive disorder. Arch Neurol. 2012;69(1):72–7.

    Article  PubMed Central  PubMed  Google Scholar 

  • Asch SM, Kilbourne AM, Gifford AL, Burnam MA, Turner B, Shapiro MF, Bozzette SA, HCSUS Consortium. Underdiagnosis of depression in HIV: who are we missing? J Gen Intern Med. 2003;18(6):450.

    Article  PubMed Central  PubMed  Google Scholar 

  • Becker JT, Kingsley L, Mullen J, Cohen B, Martin E, Miller EN, Ragin A, Sacktor N, Selnes OA, Visscher BR. Vascular risk factors, HIV serostatus and cognitive dysfunction in gay/bisexual men. Neurology. 2009;73(16):1292–9.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Brew BJ. AIDS dementia complex. In: HIV neurology. 1st ed. New York: Oxford University Press; 2001.

    Google Scholar 

  • Brew BJ, Cysique LA. Alzheimer disease and HIV: a tangled story. Neurology. 2010;75:105–6.

    Google Scholar 

  • Brew BJ, Crowe SM, Landay A, Cysique LA, Guillemin G. Neurodegeneration and ageing in the HAART era. J Neuroimmune Pharmacol. 2009;4(2):163–74.

    Article  PubMed  Google Scholar 

  • Cohen RA, Gongvatana A. The persistence of HIV-associated neurocognitive dysfunction and the effects of comorbidities. Neurology. 2010;75:2052–3.

    Article  PubMed  Google Scholar 

  • Currier JS, Lundgren JD, Carr A, Klein D, Sabin CA, Sax PE, Schouten JT, Smieja M. Epidemiological evidence for cardiovascular disease in HIV-infected patients and relationship to highly active antiretroviral therapy. Circulation. 2008;118:e29–35.

    Article  CAS  PubMed  Google Scholar 

  • Cysique LA, Maruff P, Brew BJ. Prevalence and pattern of neuropsychological impairment in human immunodeficiency virus–infected/acquired immunodeficiency syndrome (HIV/AIDS) patients across pre- and post-highly active antiretroviral therapy eras: a combined study of two cohorts. J NeuroVirol. 2004;10:350–7.

    Article  PubMed  Google Scholar 

  • Fedele F, Bruno N, Mancone M. Cardiovascular risk factors and HIV disease. AIDS Rev. 2011;13(2):119–29.

    PubMed  Google Scholar 

  • Foley J, Ettenhofer M, Wright M, Hinkin CH. Emerging issues in the neuropsychology of HIV infection. Curr HIV/AIDS Rep. 2008;5(4):204–11.

    Article  PubMed Central  PubMed  Google Scholar 

  • Garvey LJ, Pflugrad H, Thiyagarajan A, et al. Effects of active HCV replication on neurologic status in HIV RNA virally suppressed patients. Neurology. 2010;74:779.

    Article  CAS  PubMed  Google Scholar 

  • Gheuens S, Wuthrich C, Koralnik I. Progressive multifocal leukoencephalopathy:why gray and white matter? Annu Rev Pathol Mech Dis. 2013;8:189–215.

    Article  CAS  Google Scholar 

  • Gourevitch MN, Friedland GH. Interactions between methadone and medications used to treat HIV infection: a review. Mt Sinai J Med. 2000;67(5–6):429.

    CAS  PubMed  Google Scholar 

  • Hinkin CH, Castellon SA, Levine AJ, et al. Neurocognition in individuals co-infected with HIV and hepatitis C. J Addict Dis. 2008;27:11–7.

    Article  PubMed Central  PubMed  Google Scholar 

  • Hogg RS, Althoff KN, Samji H, Cescon A, Modur S, Buchacz K, Burchell AN, Cohen M, Gebo KA, Gill MJ, Justice A, Kirk G, Klein MB, Korthuis PT, Martin J, Napravnik S, Rourke SB, Sterling TR, Silverberg MJ, Deeks S, Jacobson LP, Bosch RJ, Kitahata MM, Goedert JJ, Moore R, Gange SJ, for the North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD) of the IeDEA. Increases in life expectancy among treated HIV-positive individuals in the United States and Canada, 2000–2007. IAS 2013 conference poster. http://pag.ias2013.org/Abstracts.aspx?AID=2451. Accessed 15 Oct 2013.

  • Koralnik IJ. Progressive multifocal leukoencephalopathy revisited: has the disease outgrown its name? Ann Neurol. 2006;60(2):162.

    Article  PubMed  Google Scholar 

  • Letendre SL, Cherner M, Ellis RJ, et al. The effects of hepatitis C, HIV, and methamphetamine dependence on neuropsychological performance: biological correlates of disease. AIDS. 2005;19 Suppl 3:S72–8.

    Article  CAS  PubMed  Google Scholar 

  • Margolin A, Avants SK, Warburton LA, Hawkins KA. Factors affecting cognitive functioning in a sample of human immunodeficiency virus-positive injection drugusers. AIDS Patient Care STDS. 2002;16(6):255–67.

    Article  PubMed  Google Scholar 

  • Nguyen TP, Soukup VM, Gelman BB. Persistent hijacking of brain proteasomes in HIV-associated dementia. Am J Pathol. 2010;176(2):893–902.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Schouten J, Cinque P, Gisslen M, Reiss P, Portegies P. HIV-1 infection and cognitive impairment in the cART era: a review. AIDS. 2011;25:561–75.

    Article  PubMed  Google Scholar 

  • Simioni S, Cavassini M, Annoni JM, Métral M, Iglesias K, Abraham AR, Jilek S, Calmy A, Müller H, Fayet-Mello A, Giacobini E, Hirschel B, Du Pasquier RA. Rivastigmine for HIV-associated neurocognitive disorders. Neurology. 2013;80:553–60.

    Article  CAS  PubMed  Google Scholar 

  • Spronk DB, van Wel JH, Ramaekers JG, Verkes RJ. Characterizing the cognitive effects of cocaine: a comprehensive review. Neurosci Biobehav Rev. 2013;37(8):1838–59.

    Article  CAS  PubMed  Google Scholar 

  • Thein H-H, Maruff P, Krahn M, Kaldor JM, Koorey DJ, Brew BJ, Dore GJ. Improved cognitive function, mood, and health-related quality of life in HCV monoinfected and HIV/HCV coinfected individuals with pegylated interferon alfa-2a and ribavirin. HIV Med. 2007;8(8):520–8.

    Article  CAS  PubMed  Google Scholar 

  • Wilkinson J, Radkowski M, Laskus T. Hepatitis C virus neuroinvasion: identification of infected cells. J Virol. 2009;83:1312–9.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Bruce J. Brew .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer Science+Business Media New York

About this entry

Cite this entry

Garber, J.Y., Brew, B.J. (2015). Differential Diagnosis of HIV-Associated Neurocognitive Disorders. In: Hope, T., Stevenson, M., Richman, D. (eds) Encyclopedia of AIDS. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-9610-6_215-1

Download citation

  • DOI: https://doi.org/10.1007/978-1-4614-9610-6_215-1

  • Received:

  • Accepted:

  • Published:

  • Publisher Name: Springer, New York, NY

  • Online ISBN: 978-1-4614-9610-6

  • eBook Packages: Springer Reference MedicineReference Module Medicine

Publish with us

Policies and ethics